Searching Case Laws & Precedent on Legal Query.....!
Analysing the retrieved Case Laws
Scanned Judgements…!
Searching Case Laws & Precedent on Legal Query.....!
Analysing the retrieved Case Laws
Scanned Judgements…!
The initial seizure and storage procedures are crucial for establishing the integrity of the drug samples before analysis ["PUBLIC PROSECUTOR vs LEE BOON SENG - High Court"].
During Analysis - Chemist’s Role and Scientific Process
The chemist's findings are trusted unless proven inherently incredible, and their reports serve as corroborative evidence supporting the prosecution's case ["PP vs TERUMURUGAN KOLANDAI GOUNDER - High Court"].
Differences in Substances and Identification
The chemist's ability to explain transformations between substances (e.g., methamphetamine to ketamine) was limited, but the analysis results are accepted as conclusive evidence of the drug's nature at the time of analysis [](https://supremetoday.ai/doc/judgement/MY_MLRH_2010_18_MLRH_101).
Conclusion
In high-stakes Malaysian drug cases, the reliability of forensic evidence from chemists can make or break a conviction. A pivotal question arises: What is the legal distinction in Malaysian drug cases between evidence before and during drug analysis by a chemist? This issue hinges on how courts evaluate the chemist's opinion versus the integrity of laboratory procedures. Understanding this divide is essential for legal professionals, defendants, and anyone navigating the Dangerous Drugs Act 1952 (DDA).
This article delves into key judgments, highlighting when chemist testimony is accepted on face value and when procedural flaws—like improper homogenization—can render evidence unreliable, potentially leading to an unsafe conviction. We'll explore core principles, supported by case references, and integrate insights from related Malaysian precedents on sample handling and analysis.
The distinction boils down to two phases:
This framework ensures forensic evidence meets rigorous standards under the DDA, where penalties can include death or life imprisonment.
Prior to diving into lab work, the chemist's primary duty is to confirm the substance's nature—not ownership or control PP vs MOK CHEN LOON - 2009 MarsdenLR 1179. Malaysian courts typically rely on the chemist's credible testimony without demanding step-by-step records, unless challenged.
For instance, proper handover of exhibits is crucial. In one case, the chemist confirmed receiving marked exhibits 'CKB1(a)', 'CKB2(a)', and 'CKB3(a)' for analysis, matching police records, which bolstered the chain of custody PP vs ZULKAHAR DUSING. Similarly, the chemist's report (P10) verified 3,797.2 grams of methamphetamine, supporting trafficking charges under the DDA Schedule 2 PP vs LEE YU HUAT.
These examples show that pre-analysis credibility stems from consistent identification and unchallenged expert opinion. Courts presume reliability unless rebutted, streamlining trials while safeguarding justice.
Once analysis begins, precision is paramount. Homogenization—blending the sample for uniformity—is a cornerstone step. Flawed execution here compromises representativeness, tainting results MUHAMMAD KHUDZAIRI MARFUJI vs PP - 2009 MarsdenLR 203.
A landmark judgment quashed a conviction due to serious inconsistencies in the homogenization process, deeming the evidence unreliable NOLOSE ALBERT RALESHOME vs PP - 2014 MarsdenLR 1020. The court emphasized: methods must be appropriate and correctly executed, even if not all are applied MUHAMMAD KHUDZAIRI MARFUJI vs PP - 2009 MarsdenLR 203.
In another scenario, the seized drug was handed to chemist SP2, who confirmed cannabis (1948.3 grams) and meth (68.06 grams) under DDA— but only after verifying the impugned drug's chain PP vs AZRIL SANI RAMUDIN & ANOR. Procedural lapses during this phase invite scrutiny, as they directly impact identification accuracy.
Malaysian courts stress that forensic integrity underpins DDA prosecutions. Pre-analysis acceptance relies on expert credibility, but during-analysis errors shift the burden. If homogenization fails, the drug's identification may be questioned, affecting trial outcomes.
Related precedents reinforce chain of custody: Suspected drugs sent to chemists must align with court exhibits, as seen where PW7 confirmed analyzed items PP vs ZULKAHAR DUSING. In trafficking cases, failure to prove prima facie possession via reliable analysis led to acquittals on major charges PP vs LEE YU HUAT.
While some international cases highlight delays invalidating samples (e.g., under India's Drugs and Cosmetics Act), Malaysian focus remains on procedural execution over timelines, provided custody is intact P.R.Naik vs State of Maharashtra - 2024 Supreme(Bom) 1143.
Chemist evidence isn't invincible. It's rejected if:- Inherently incredible PP vs MOK CHEN LOON - 2009 MarsdenLR 1179.- Rebutted by defense.- Marred by critical flaws like homogenization inconsistencies NOLOSE ALBERT RALESHOME vs PP - 2014 MarsdenLR 1020.
Defense counsel can challenge by probing lab logs, cross-examining on methods, or highlighting mismatches in handover PP vs AZRIL SANI RAMUDIN & ANOR. Courts assess if errors significantly affect substance identification.
To uphold justice:- Forensic labs: Adhere strictly to homogenization and standardization MUHAMMAD KHUDZAIRI MARFUJI vs PP - 2009 MarsdenLR 203.- Courts: Scrutinize processes in severe penalty cases.- Defense: Target procedural flaws early, especially in analysis phases.- Prosecution: Ensure seamless exhibit transfer to chemists PP vs ZULKAHAR DUSING.
| Phase | Court Approach | Risks/Challenges ||-------|----------------|--------------------|| Before Analysis | Accept credible opinion PP vs MOK CHEN LOON - 2009 MarsdenLR 1179 | Inherent incredibility or rebuttal || During Analysis | Demand proper procedures MUHAMMAD KHUDZAIRI MARFUJI vs PP - 2009 MarsdenLR 203 | Homogenization flaws → Unsafe conviction NOLOSE ALBERT RALESHOME vs PP - 2014 MarsdenLR 1020 |
In summary, while pre-analysis testimony enjoys presumptive weight, during-analysis rigor is non-negotiable. These distinctions protect against miscarriages in Malaysian drug law.
This article provides general insights based on reported cases and is not legal advice. Consult a qualified Malaysian lawyer for case-specific guidance.
[21] PW1 conducted an analysis of the items, and the analysis results confirmed that the substance is the dangerous drug known as Methamphetamine, with a weight of 678.7 grams p class="para para" data-keyword="chemist confirms drugs ... that was sent to the chemist for analysis and it is that same substance that is found to be heroin or cannabis etc. and it is in respect of that substance that an accused is charged with trafficking. ... [20] On 24 August 2020, at around 2:34 PM, at the Malays....
SP9 then on 26 November 2014 directed SP2 to take further photographs of the case materials to be sent to the Malaysian Chemistry Department in boxes for testing and analysis. ... Otherwise, if the aforesaid drug exhibits were those sent to the Malaysian Chemistry Department for analysis, then the drug exhibits kept in the storeroom were not those analysed by SP3. The difference in the testimony of SP1 and SP9 is irreconcilable with that of SP2. ... [24] That notwith....
On the same day he sent P2 to Chemistry Department for chemical analysis where the exhibit was received by the Chemist (PW1). The exhibits after analysis were sealed inside its original box with safe label and laboratory number of Malaysian Chemist Department. ... in the weight of the drug exhibit as found by the police and the chemist. ... PW1 stated in the Chemist Report [Exh P4] that the net weight of the drug was 1,811 grams whi....
It is also the same exhibits that was handed over to the chemist for analysis which he identified in Court . In any case, Abdul Hamid JCA (as he then was) in Gunalan Ramachandran & Ors v. ... [26] PW7, the chemist, further confirmed that the exhibits he received for analysis were marked as 'CKB1(a)', 'CKB2(a)', and 'CKB3(a)'. ... The items described in these documents especially the ones sent for analysis are the same ones recorded in the POL 31 application P17(1-2) and the #HL_START....
[69] The findings of the analysis conducted by PW2 were recorded in a Chemist Report (Exhibit P22). ... in a dangerous drug. ... They all held that the Court is entitled to accept the testimony of the chemist at face value without the necessity of him or her going into the details of their analysis unless it is inherently incredible. ... Trafficking in dangerous drug. ... PW2 duly recorded his findings in a Chemist Report (Exhibit P22).
Infact the chemist herself when asked, was unable to explain how the drug methamphetamine can change to ketamine. However, as the prosecution's case unfolded to its end, the 'strange phenomena' was explained. ... The 46 packets of white crystalline substance were then sealed and kept by Misell ak Rondeng in a silver metal brief case and the brief case was put in an iron safe in his office before he sent them to the chemist on 19.3.2009. The chemist, Ms. ... When the....
Next he has stated and admitted the fact that his analyst started analysis of the subject drug on 5.4.1994 and completed the analysis on 22.04.1994. ... Brahmabhatt was working as Production Chemist whereas Accused No.9 Mrs. Ranikumar was working as Quality Control Chemist with M/s. Healer (India) Laboratories. Independently, M/s. ... Brahmabhatt was employed as Production Chemist in the same laboratory. In the above backdrop, the facts of the case, which are in a nar....
The suspected drugs were sent to be analysed by the chemist (SP1). Vide the chemist report (P10), SP1 confirmed the drugs to weigh 3,797.2 grams of methamphetamine which is listed in Schedule 2 DDA. ... One charge is for drug trafficking 3,797.2 grams of methamphetamine. The second charge is for drug possession of 0.78 grams of 3.4-Methylenedioxymenthamphetamine (MDMA). The other charge is for drug possession of 0.78 grams of ketamine. The charge for drug trafficking under a href=".. .....
Infact the chemist herself when asked, was unable to explain how the drug methamphetamine can change to ketamine. However, as the prosecution's case unfolded to its end, the 'strange phenomena' was explained. ... The 46 packets of white crystalline substance were then sealed and kept by Misell ak Rondeng in a silver metal brief case and the brief case was put in an iron safe in his office before he sent them to the chemist on 19.3.2009. The chemist, Ms. ... This is b....
[8] So as not to lose track of the impugned drug, the same seized was later handed over for chemical test and analysis on its nature and identity to the chemist SP2 which was then produced in court as exhibits in order to support proof of the preferred charges against ... The impugned drug which was later handed over to the chemist SP2 was confirmed as dangerous drug pursuant to the DDA to wit cannabis weighing 1948.3 grams and meth weighing 68.06 grams [14] Inappropriate and illogica....
The necessary investigation was conducted, and it was found that the name of M/s Unison Pharmaceuticals was changed to M/s VADSP Pharmaceuticals. The Firm replied to the notice and requested retesting. The second sample was sent to the Central Drugs Testing Laboratory, Kolkata, which issued a report declaring that the sample was not of standard quality. Accused Nos. 1 to 3, being a manufacturing firm, had manufactured the drug, which was not of standard quality; hence, the complaint was filed against them for taking action as per the law. e. Regional Drugs Testing Laboratory, Sector 39-C, Ch....
In the year 1993-94, the said company proposed to launch a pharmaceutical project and therefore, required a drug licence. Pandey were availed and it was agreed that after successful commencement of the project, Mr. L.D. For obtaining a drug licence, the company was required to have a chemist/drug licence holder on its employment.
In the year 1993-94, the said company proposed to launch a pharmaceutical project and therefore, required a drug licence. For obtaining a drug licence, the company was required to have a chemist/drug licence holder on its employment. Pandey were availed and it was agreed that after successful commencement of the project, Mr. L.D.
The drug of the defendant under the mark ‘HEPROTEC’is prescribed by doctors to patients suffering from liver related ailments other than hepatitis. The drug of the plaintiff ‘HEPITEC’ is a schedule ‘H’ drug and thus is prescribed by a doctor and can be dispensed with by a qualified druggist/chemist only. The said drug is prescribed to patients diagnosed with HIV-I, HIV-2 or hepatitis B virus. The drug of the defendant under the mark ‘HEPROTEC’is prescribed by doctors to patients suffering from liver related ailments other than hepatitis. The drug of the plaintiff ....
To purchase such drug, the medical prescription of a registered medical practitioner is must and even as per the relevant rules. Chemist cannot sell such drug without there being such prescription,
Login now and unlock free premium legal research
Login to SupremeToday AI and access free legal analysis, AI highlights, and smart tools.
Login
now!
India’s Legal research and Law Firm App, Download now!
Copyright © 2023 Vikas Info Solution Pvt Ltd. All Rights Reserved.